• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Heart transplantation using bivalirudin as anticoagulant.

作者信息

Simsir Sinan A, Schwarz Ernst R, Czer Lawrence S C, Hamburg Solomon I

机构信息

Division of Cardiothoracic Surgery, Cedars-Sinai Medical Center, Los Angeles, California 90048, USA.

出版信息

Interact Cardiovasc Thorac Surg. 2010 Jan;10(1):150-1. doi: 10.1510/icvts.2009.218172. Epub 2009 Oct 1.

DOI:10.1510/icvts.2009.218172
PMID:19797475
Abstract

We present the case of a man with heparin-induced thrombocytopenia (HIT) and acute idiopathic decompensated cardiomyopathy who underwent successful heart transplantation with the use of bivalirudin as anticoagulant.

摘要

相似文献

1
Heart transplantation using bivalirudin as anticoagulant.
Interact Cardiovasc Thorac Surg. 2010 Jan;10(1):150-1. doi: 10.1510/icvts.2009.218172. Epub 2009 Oct 1.
2
Successful use of bivalirudin for cardiac transplantation in a child with heparin-induced thrombocytopenia.比伐卢定成功用于一名患有肝素诱导的血小板减少症儿童的心脏移植手术。
J Heart Lung Transplant. 2006 Nov;25(11):1376-9. doi: 10.1016/j.healun.2006.08.005. Epub 2006 Oct 11.
3
Novel techniques in the use of bivalirudin for cardiopulmonary bypass anticoagulation in a child with heparin-induced thrombocytopenia.在一名患有肝素诱导的血小板减少症的儿童中使用比伐卢定进行体外循环抗凝的新技术。
Perfusion. 2011 Nov;26(6):516-8. doi: 10.1177/0267659111419037. Epub 2011 Aug 9.
4
Bivalirudin Anticoagulation for a Pediatric Patient with Heparin-Induced Thrombocytopenia and Thrombosis Requiring Cardiopulmonary Bypass for Ventricular Assist Device Placement.比伐卢定用于一名患有肝素诱导的血小板减少症和血栓形成且需要体外循环进行心室辅助装置植入的儿科患者的抗凝治疗。
J Extra Corpor Technol. 2016 Mar;48(1):39-42.
5
Anticoagulant monitoring techniques in a heparin-induced thrombocytopenia patient undergoing cardiopulmonary bypass using bivalirudin anticoagulant.在使用比伐卢定抗凝剂进行体外循环的肝素诱导的血小板减少症患者中的抗凝监测技术。
J Extra Corpor Technol. 2004 Dec;36(4):371-4.
6
Cardiopulmonary bypass with bivalirudin in type II heparin-induced thrombocytopenia.在II型肝素诱导的血小板减少症中使用比伐卢定进行体外循环。
Ann Thorac Surg. 2004 Dec;78(6):2167-9. doi: 10.1016/S0003-4975(03)01471-1.
7
Bivalirudin during cardiopulmonary bypass in patients with previous or acute heparin-induced thrombocytopenia and heparin antibodies: results of the CHOOSE-ON trial.既往有或新发肝素诱导的血小板减少症及肝素抗体患者在体外循环期间使用比伐卢定：CHOOSE-ON试验结果
Ann Thorac Surg. 2007 Feb;83(2):572-7. doi: 10.1016/j.athoracsur.2006.09.038.
8
Bivalirudin anticoagulation for cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia.比伐卢定用于肝素诱导的血小板减少症患者体外循环抗凝。
Can J Anaesth. 2005 Dec;52(10):1093-8. doi: 10.1007/BF03021611.
9
Management of refractory bleeding post-cardiopulmonary bypass in an acute heparin-induced thrombocytopenia type II renal failure patient who underwent urgent cardiac surgery with bivalirudin (Angiox) anticoagulation.一名急性II型肝素诱导的血小板减少症合并肾衰竭患者在接受使用比伐卢定（安其罗）抗凝的紧急心脏手术后，体外循环后难治性出血的管理。
Perfusion. 2018 Apr;33(3):235-240. doi: 10.1177/0267659117723457. Epub 2017 Aug 8.
10
Case report: a thrombus in the venous reservoir while using bivalirudin in a patient with heparin-induced thrombocytopenia undergoing heart transplantation.病例报告：在接受肝素诱导的血小板减少症的心脏移植患者中使用比伐卢定期间，静脉储液器中出现血栓。
Anesth Analg. 2010 Sep;111(3):609-12. doi: 10.1213/ANE.0b013e3181e9ead3. Epub 2010 Aug 4.

引用本文的文献

1
Simultaneous Liver-Kidney Transplantation in Patient with a History of Heparin-Induced Thrombocytopenia: A Case Report and Literature Review.有肝素诱导的血小板减少症病史患者的同期肝肾联合移植：病例报告及文献综述
Am J Case Rep. 2019 Jul 9;20:980-987. doi: 10.12659/AJCR.916717.
2
Alternative anticoagulation during cardiovascular procedures in pediatric patients with heparin-induced thrombocytopenia.肝素诱导的血小板减少症患儿心血管手术期间的替代抗凝治疗。
J Extra Corpor Technol. 2012 Jun;44(2):69-74.